BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pham T, Roth S, Kong J, Guerra G, Narasimhan V, Pereira L, Desai J, Heriot A, Ramsay R. An Update on Immunotherapy for Solid Tumors: A Review. Ann Surg Oncol 2018;25:3404-12. [DOI: 10.1245/s10434-018-6658-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Smith C, Zheng W, Dong J, Wang Y, Lai J, Liu X, Yin F. Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy. World J Gastroenterol 2022; 28(27): 3297-3313 [DOI: 10.3748/wjg.v28.i27.3297] [Reference Citation Analysis]
2 Hou S, Hasnat M, Chen Z, Liu Y, Faran Ashraf Baig MM, Liu F, Chen Z. Application Perspectives of Nanomedicine in Cancer Treatment. Front Pharmacol 2022;13:909526. [DOI: 10.3389/fphar.2022.909526] [Reference Citation Analysis]
3 Ivanics T, Mpaw C, Al-Adra D, Sapisochin G. Experience with solid organ transplantation in patients with previous immunotherapy treatment is still limited but this is changing: The survey-based view of the global transplant society. Transpl Immunol 2022;:101637. [PMID: 35667542 DOI: 10.1016/j.trim.2022.101637] [Reference Citation Analysis]
4 Cao H, Sugimura R. Off-the-Shelf Chimeric Antigen Receptor Immune Cells from Human Pluripotent Stem Cells. Cancer Treat Res 2022;183:255-74. [PMID: 35551663 DOI: 10.1007/978-3-030-96376-7_9] [Reference Citation Analysis]
5 Zhang X, Li H, Lv X, Hu L, Li W, Zi M, He Y. Impact of Diets on Response to Immune Checkpoint Inhibitors (ICIs) Therapy against Tumors. Life 2022;12:409. [DOI: 10.3390/life12030409] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Wang Y, Liu T, Li X, Sheng H, Ma X, Hao L. Ferroptosis-Inducing Nanomedicine for Cancer Therapy. Front Pharmacol 2021;12:735965. [PMID: 34987385 DOI: 10.3389/fphar.2021.735965] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Nitta H, Robida MD, Polaske N. Immunohistochemistry: Roche Tissue Diagnostics Perspective. Handbook of Practical Immunohistochemistry 2022. [DOI: 10.1007/978-3-030-83328-2_7] [Reference Citation Analysis]
8 Zhao L, Zhang S, Kepp O, Kroemer G, Liu P. Dendritic cell transfer for cancer immunotherapy. Adoptive Cell Transfer 2022. [DOI: 10.1016/bs.ircmb.2022.03.003] [Reference Citation Analysis]
9 Kim M, Seo AN. Molecular Pathology of Gastric Cancer. J Gastric Cancer 2022;22:264. [DOI: 10.5230/jgc.2022.22.e35] [Reference Citation Analysis]
10 Tang Z, Huang Z, Huang Y, Chen Y, Huang M, Liu H, Ye QA, Zhao J, Jia B. Ferroptosis: The Silver Lining of Cancer Therapy. Front Cell Dev Biol 2021;9:765859. [PMID: 34912804 DOI: 10.3389/fcell.2021.765859] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
11 Zhang T, Liu Q, Zhu Y, Zhang S, Peng Q, Strickland AL, Zheng W, Zhou F. PD-L1 Expression in Endometrial Serous Carcinoma and Its Prognostic Significance. CMAR 2021;Volume 13:9157-65. [DOI: 10.2147/cmar.s337271] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Ngamphaiboon N, Ithimakin S, Siripoon T, Sintawichai N, Sriuranpong V. Patterns and outcomes of immune-related adverse events in solid tumor patients treated with immune checkpoint inhibitors in Thailand: a multicenter analysis. BMC Cancer 2021;21:1275. [PMID: 34823493 DOI: 10.1186/s12885-021-09003-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Khan S, Mahalingam R, Sen S, Martinez-Ledesma E, Khan A, Gandy K, Lang FF, Sulman EP, Alfaro-Munoz KD, Majd NK, Balasubramaniyan V, de Groot JF. Intrinsic Interferon Signaling Regulates the Cell Death and Mesenchymal Phenotype of Glioblastoma Stem Cells. Cancers (Basel) 2021;13:5284. [PMID: 34771447 DOI: 10.3390/cancers13215284] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Ng Kee Kwong F, Brodie F, Mcarthur C, Macgregor F. A Case Report: Internal Carotid Artery Dissection Presenting as Hoarseness Secondary to Vocal Cord Palsy. EMJ Neurol 2021. [DOI: 10.33590/emjneurol/20-00208] [Reference Citation Analysis]
15 Paterson K, Zanivan S, Glasspool R, Coffelt SB, Zagnoni M. Microfluidic technologies for immunotherapy studies on solid tumours. Lab Chip 2021;21:2306-29. [PMID: 34085677 DOI: 10.1039/d0lc01305f] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
16 Zafar H, Raza F, Ma S, Wei Y, Zhang J, Shen Q. Recent progress on nanomedicine-induced ferroptosis for cancer therapy. Biomater Sci 2021;9:5092-115. [PMID: 34160488 DOI: 10.1039/d1bm00721a] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 18.0] [Reference Citation Analysis]
17 Kim DH, Bae GE, Suh KS, Ryuman D, Song KS, Kim JS, Lee SI, Yeo MK. Clinical Significance of Tumor and Immune Cell PD-L1 Expression in Gastric Adenocarcinoma. In Vivo 2020;34:3171-80. [PMID: 33144421 DOI: 10.21873/invivo.12152] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
18 Stamova S, Ott-Rötzer B, Smetak H, Schäffler K, Eder R, Fink I, Hoffmann P, Reichert TE, Beckhove P, Spanier G. Characterization and ex vivo expansion of rare in situ cytokine secreting T cell populations from tumor tissue and blood of oral squamous cell carcinoma patients. J Immunol Methods 2021;496:113086. [PMID: 34146580 DOI: 10.1016/j.jim.2021.113086] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Gkountakos A, Delfino P, Lawlor RT, Scarpa A, Corbo V, Bria E. Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patients. Ther Adv Med Oncol 2021;13:17588359211006947. [PMID: 34104224 DOI: 10.1177/17588359211006947] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Wilson K, Flood M, Narasimhan V, Pham T, Warrier S, Ramsay R, Michael M, Heriot A. Complete pathological response in rectal cancer utilising novel treatment strategies for neo-adjuvant therapy: A systematic review. Eur J Surg Oncol 2021;47:1862-74. [PMID: 33814240 DOI: 10.1016/j.ejso.2021.03.245] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Schaller TH, Snyder DJ, Spasojevic I, Gedeon PC, Sanchez-Perez L, Sampson JH. First in human dose calculation of a single-chain bispecific antibody targeting glioma using the MABEL approach. J Immunother Cancer 2020;8:e000213. [PMID: 32273346 DOI: 10.1136/jitc-2019-000213] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
22 Noronha V, Abraham G, Patil V, Joshi A, Menon N, Mahajan A, Janu A, Jain S, Talreja VT, Kapoor A, Kumar Singh G, Khaddar S, Gupta K, Rathinasamy N, Srinivas S, Agrawal A, Ventrapati P, Prabhash K. A real-world data of Immune checkpoint inhibitors in solid tumors from India. Cancer Med 2021;10:1525-34. [PMID: 33591635 DOI: 10.1002/cam4.3617] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
23 Qiang W, Dai Y, Xing X, Sun X. Identification and validation of a prognostic signature and combination drug therapy for immunotherapy of head and neck squamous cell carcinoma. Comput Struct Biotechnol J 2021;19:1263-76. [PMID: 33717423 DOI: 10.1016/j.csbj.2021.01.046] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
24 Teh J, Duncan C, Qu L, Guerra G, Narasimhan V, Pham T, Lawrentschuk N. Inguinal lymph node dissection for penile cancer: a contemporary review. Transl Androl Urol 2020;9:3210-8. [PMID: 33457292 DOI: 10.21037/tau.2019.08.37] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
25 Pesce S, Vellone VG, Marcenaro E. Female Malignancies and Immunotherapy: What's New? Cancers (Basel) 2020;12:E2909. [PMID: 33050485 DOI: 10.3390/cancers12102909] [Reference Citation Analysis]
26 Petrillo A, Smyth EC. Biomarkers for Precision Treatment in Gastric Cancer. Visc Med 2020;36:364-72. [PMID: 33178733 DOI: 10.1159/000510489] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
27 Adaptations and Advancement of Biologic Immunotherapy in the Management of Immunologically Cold Solid Malignancies. EMJ Oncol 2020. [DOI: 10.33590/emjoncol/19-00206] [Reference Citation Analysis]
28 Teh J, O'Connor E, O'Brien J, Lim WM, Taylor M, Heriot A, Ramsay R, Lawrentschuk N. Future directions in advanced penile cancer - mechanisms of carcinogenesis and a search for targeted therapy. Future Oncol 2020;16:2357-69. [PMID: 32713198 DOI: 10.2217/fon-2020-0434] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
29 Perrier A, Didelot A, Laurent-Puig P, Blons H, Garinet S. Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors. Biomolecules 2020;10:E1061. [PMID: 32708698 DOI: 10.3390/biom10071061] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 16.0] [Reference Citation Analysis]
30 Neshat SY, Tzeng SY, Green JJ. Gene delivery for immunoengineering. Curr Opin Biotechnol 2020;66:1-10. [PMID: 32554325 DOI: 10.1016/j.copbio.2020.05.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
31 Luchini C, Bibeau F, Ligtenberg MJL, Singh N, Nottegar A, Bosse T, Miller R, Riaz N, Douillard JY, Andre F, Scarpa A. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach. Ann Oncol 2019;30:1232-43. [PMID: 31056702 DOI: 10.1093/annonc/mdz116] [Cited by in Crossref: 322] [Cited by in F6Publishing: 351] [Article Influence: 161.0] [Reference Citation Analysis]
32 Beer A, Taghizadeh H, Schiefer AI, Puhr HC, Karner AK, Jomrich G, Schoppmann SF, Kain R, Preusser M, Ilhan-Mutlu A. PD-L1 and HER2 Expression in Gastroesophageal Cancer: a Matched Case Control Study. Pathol Oncol Res 2020;26:2225-35. [PMID: 32372174 DOI: 10.1007/s12253-020-00814-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
33 Khan S, Mittal S, McGee K, Alfaro-Munoz KD, Majd N, Balasubramaniyan V, de Groot JF. Role of Neutrophils and Myeloid-Derived Suppressor Cells in Glioma Progression and Treatment Resistance. Int J Mol Sci 2020;21:E1954. [PMID: 32182988 DOI: 10.3390/ijms21061954] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 14.5] [Reference Citation Analysis]
34 Shan X, Li S, Sun B, Chen Q, Sun J, He Z, Luo C. Ferroptosis-driven nanotherapeutics for cancer treatment. Journal of Controlled Release 2020;319:322-32. [DOI: 10.1016/j.jconrel.2020.01.008] [Cited by in Crossref: 75] [Cited by in F6Publishing: 78] [Article Influence: 37.5] [Reference Citation Analysis]
35 Sanjari-moghaddam A, Sadeghi F, Soleyman-jahi S. Immunotherapy of Gastric and Esophageal Cancers. Cancer Immunology 2020. [DOI: 10.1007/978-3-030-57949-4_8] [Reference Citation Analysis]
36 Dobosz P, Dzieciątkowski T. The Intriguing History of Cancer Immunotherapy. Front Immunol 2019;10:2965. [PMID: 31921205 DOI: 10.3389/fimmu.2019.02965] [Cited by in Crossref: 116] [Cited by in F6Publishing: 120] [Article Influence: 38.7] [Reference Citation Analysis]
37 Topper MJ, Vaz M, Marrone KA, Brahmer JR, Baylin SB. The emerging role of epigenetic therapeutics in immuno-oncology. Nat Rev Clin Oncol. 2020;17:75-90. [PMID: 31548600 DOI: 10.1038/s41571-019-0266-5] [Cited by in Crossref: 148] [Cited by in F6Publishing: 157] [Article Influence: 49.3] [Reference Citation Analysis]
38 Kasten BB, Udayakumar N, Leavenworth JW, Wu AM, Lapi SE, McConathy JE, Sorace AG, Bag AK, Markert JM, Warram JM. Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-Oncology. Theranostics 2019;9:5085-104. [PMID: 31410203 DOI: 10.7150/thno.34415] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
39 Das SK, Sarkar D, Emdad L, Fisher PB. MDA-9/Syntenin: An emerging global molecular target regulating cancer invasion and metastasis. Adv Cancer Res 2019;144:137-91. [PMID: 31349898 DOI: 10.1016/bs.acr.2019.03.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
40 Kenny RG, Marmion CJ. Toward Multi-Targeted Platinum and Ruthenium Drugs-A New Paradigm in Cancer Drug Treatment Regimens? Chem Rev 2019;119:1058-137. [PMID: 30640441 DOI: 10.1021/acs.chemrev.8b00271] [Cited by in Crossref: 309] [Cited by in F6Publishing: 321] [Article Influence: 103.0] [Reference Citation Analysis]
41 Pham T, Carpinteri S, Sampurno S, Pereira L, Roth S, Narasimhan V, Darcy P, Desai J, Heriot AG, Ramsay RG. Novel Vaccine Targeting Colonic Adenoma: a Pre-clinical Model. J Gastrointest Surg 2019;23:626-33. [PMID: 30623377 DOI: 10.1007/s11605-018-4060-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Yelton CJ, Ray SK. Histone deacetylase enzymes and selective histone deacetylase inhibitors for antitumor effects and enhancement of antitumor immunity in glioblastoma. Neuroimmunol Neuroinflamm 2018;5:46. [PMID: 30701185 DOI: 10.20517/2347-8659.2018.58] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
43 Pham T, Roth S, Desai J, Ramsay R, Heriot A. ASO Author Reflections: Immunotherapy for Solid Tumors: A Review. Ann Surg Oncol 2018;25:974-5. [PMID: 30377919 DOI: 10.1245/s10434-018-6966-8] [Reference Citation Analysis]